Tralokinumab

Adtralza

Managing moderate-to-severe atopic dermatitis can be challenging, but Adtralza offers targeted relief by blocking interleukin-13 (IL-13), a key protein responsible for eczema-related inflammation. This FDA-approved biologic treatment helps reduce redness, itching, and flare-ups, improving overall skin health and comfort. Designed for subcutaneous injection, Adtralza follows a structured dosing regimen: 600 mg as a loading dose, followed by 300 mg every two weeks, with the potential for monthly maintenance in well-controlled patients. Its precision-targeted approach makes it an effective alternative to traditional immunosuppressants. Buy Adtralza to manage atopic dermatitis today and take a step toward long-term symptom relief with a trusted, clinically proven treatment delivered conveniently to your door!

Product Overview

Adtralza is a targeted biologic therapy that helps manage moderate-to-severe atopic dermatitis by blocking interleukin-13 (IL-13), a key protein responsible for skin inflammation. By addressing the root cause, Adtralza offers long-term symptom control, reducing redness, itching, and inflammation, and promoting clearer, healthier skin. Unlike traditional treatments, this innovative therapy provides consistent relief for those struggling with persistent eczema.

Adtralza is administered via subcutaneous injection, making it a convenient option for those who prefer a self-administered treatment plan under the guidance of their healthcare provider. The standard dosing includes a 600 mg loading dose, followed by 300 mg every two weeks, with the possibility of switching to monthly injections for well-controlled patients.

If affordability is a concern, we offer competitive pricing and discounts, allowing you to buy Adtralza to manage atopic dermatitis without financial strain. At Polar Bear Meds, you can purchase authentic, high-quality Adtralza at a lower cost compared to local pharmacies. Use our special coupon code “WELCOMEPB10” for 10% off your first order and experience cost-effective relief. Don’t let eczema interfere with your daily life. Buy Adtralza online from Canada today and take control of your skin health with a trusted and clinically proven treatment delivered straight to your door!

What Are the Uses of Adtralza?

Adtralza is primarily used for the treatment of:

• Moderate-to-severe atopic dermatitis in adults and adolescents aged 12 years and older who are candidates for systemic therapy. 

What Are the Forms & Strengths of Adtralza?

Adtralza is available in the following forms and strengths:

• Pre-filled Syringe: Each single-use syringe contains 150 mg of tralokinumab in 1 mL solution (150 mg/mL).
• Pre-filled Pen: Each single-use pen contains 300 mg of tralokinumab in 2 mL solution (150 mg/mL). 

What Is the Recommended Dosage of Adtralza?

Determining the right dosage of Adtralza is essential for achieving optimal treatment outcomes. The following recommended dosing regimen includes an initial loading dose followed by maintenance injections, with potential adjustments based on individual response. Special considerations apply to certain populations, ensuring safe and effective use.

Standard Recommended Dosage in Adults

• Initial Dose (Loading Dose):

1. 1. • 600 mg by subcutaneous injection (this is typically given as four 150 mg injections) at Week 0.

• Maintenance Dose:

1. • 300 mg by subcutaneous injection (two 150 mg injections) every 2 weeks, starting at Week 2.

Potential Adjustments

• After 16 Weeks of Treatment:

• • • If a patient who weighs <100 kg has achieved clear or almost clear skin (or is otherwise well-controlled), the dosing frequency may be decreased to 300 mg every 4 weeks for maintenance.
    • If the patient experiences a loss of disease control on the every-4-weeks schedule, the dose frequency can be increased back to every 2 weeks.

• Lack of Response at Week 16:

• • If the patient has not experienced adequate improvement, some clinicians may consider continuing therapy beyond 16 weeks, but some guidelines suggest discontinuation if there is no meaningful benefit by then. This decision is made on a case-by-case basis.

Special Populations

• Pediatric Use:

• • • Adtralza (tralokinumab) is primarily indicated for adults with moderate-to-severe atopic dermatitis. Consult a pediatric specialist if you are considering use in younger individuals, as dosing recommendations may not be established.

• Renal or Hepatic Impairment:

• • Specific dose adjustments in patients with renal or hepatic impairment have not been well characterized. Clinicians typically monitor these patients more closely, but no formal alternative dosage is currently specified.

Geriatric Patients:

• No specific dose adjustment is typically required, but as with any medication, older adults should be monitored for tolerability and side effects.

[Note: Remember, these recommendations may vary from person to person. Discuss it with your doctor, and they’ll customize your dosage accordingly.]

How to Use Adtralza?

Proper use of Adtralza is essential to ensure its effectiveness and minimize potential side effects. Follow the guidelines given below to maintain consistent treatment results while ensuring a smooth and comfortable injection process.

• Initial Dose (Loading Dose):

• • • Inject 600 mg (four 150 mg injections) under the skin on the first day (Week 0).

• Maintenance Dose:

• • Inject 300 mg (two 150 mg injections) every 2 weeks starting from Week 2.
  • Some patients may be eligible for every 4-week dosing after 16 weeks if their symptoms are well controlled.

• Injection Site Options:

• • • Administer Adtralza into the thigh, abdomen (avoiding a 2-inch radius around the navel), or upper arm.
    • Rotate injection sites to prevent irritation or discomfort.

• Preparing for Injection:

• • • Remove Adtralza from the refrigerator and let it reach room temperature for about 30 minutes before use.
    • Inspect the medication—do not use it if it appears cloudy or contains particles.

• Administering the Injection:

• • • Clean the injection site with an alcohol swab and let it dry.
    • Pinch the skin and insert the needle at a 45- to 90-degree angle.
    • Press the plunger until all the medication is injected.

• After Injection:

• • Withdraw the needle and apply light pressure with a cotton ball or gauze (do not rub).
  • Dispose of the used syringe in a sharps disposal container.

[Note: Your doctor will decide the right amount for you based on your condition, following guidelines and studies on the drug. They’ll adjust it as needed over time.]

How Does Adtralza Work?

Adtralza works by targeting and blocking a specific protein in your body called interleukin-13 (IL-13). IL-13 plays a crucial role in the inflammation and irritation that cause the symptoms of eczema, such as redness, itching, and swelling of the skin. By inhibiting IL-13, Adtralza helps reduce this inflammation, leading to calmer and healthier skin. This targeted action not only alleviates the uncomfortable symptoms of moderate to severe atopic dermatitis but also helps improve the overall condition of the skin over time. Adtralza is administered through injections, typically every two weeks, to maintain its effectiveness in managing and controlling eczema symptoms, allowing individuals to experience fewer flare-ups and better quality of life.

Important Safety Information for Using Adtralza

What Are the Side Effects of Adtralza?

Like all medications, Adtralza may cause side effects in some individuals. Below is a detailed list of the common side effects associated with this medication, each explained to help you understand what to expect.

• Injection Site Reactions: One of the most frequently reported side effects of Adtralza. These reactions can include pain, redness, swelling, or itching at the site where the injection was administered. Such reactions typically occur shortly after the injection and may last for a few hours to a few days. While generally mild to moderate in severity, persistent or severe reactions should be discussed with a healthcare provider. Rotating injection sites can help minimize these reactions and improve comfort during administration.
• Conjunctivitis (Red or Watery Eyes): Commonly known as pink eye, is another common side effect of Adtralza. This condition involves inflammation or irritation of the conjunctiva, the clear tissue covering the white part of the eye and the inside of the eyelids. Symptoms may include redness, itching, a gritty feeling, discharge, and increased tearing. While conjunctivitis associated with Adtralza is usually mild to moderate, it can be uncomfortable and may require treatment with lubricating eye drops or other medications as advised by your healthcare provider.
• Upper Respiratory Tract Infections: Patients taking Adtralza may experience upper respiratory tract infections, such as the common cold, sinusitis, or pharyngitis. These infections involve inflammation of the nose, throat, and airways, leading to symptoms like a runny or stuffy nose, sore throat, cough, and general feelings of being unwell. While most upper respiratory infections are mild and self-limiting, they can cause significant discomfort and may require symptomatic treatment. If symptoms worsen or do not improve, it is important to seek medical attention.
• Headaches: One of the most commonly reported side effects for individuals using Adtralza. These headaches can range from mild to moderate in intensity and may be characterized by a persistent ache, throbbing pain, or pressure in various parts of the head. While headaches are usually manageable with over-the-counter pain relievers and rest, they can sometimes interfere with daily activities and quality of life. If headaches become severe, frequent, or are accompanied by other concerning symptoms, consulting a healthcare provider is recommended.
• Fatigue (Tiredness): A general feeling of tiredness and lack of energy, is another side effect that some patients may experience while taking Adtralza. This sensation can affect daily functioning, making routine tasks feel more strenuous and reducing overall productivity. Fatigue can result from the body’s response to the medication or as a consequence of improved skin condition and reduced inflammation. Ensuring adequate rest, maintaining a balanced diet, and staying hydrated can help manage fatigue, but a healthcare professional should evaluate persistent or debilitating tiredness.
• Nausea: This is occasionally reported by individuals using Adtralza. This side effect involves an uneasy feeling in the stomach that may precede vomiting. Nausea can vary in intensity from mild discomfort to a more distressing sensation. It can be triggered by the body’s reaction to the medication or other underlying factors. Managing nausea may include eating smaller, more frequent meals, avoiding spicy or fatty foods, staying hydrated, and using anti-nausea medications if prescribed by a healthcare provider.
• Back Pain: Some patients may experience back pain while taking Adtralza. This discomfort can range from mild to moderate and may affect either the lower or upper regions of the back. Back pain can interfere with daily activities and overall comfort. It may result from changes in the body’s inflammatory processes or other factors related to the medication. 
• Joint Pain (Arthralgia): Also known as arthralgia, is another side effect reported by some individuals taking Adtralza. This pain can affect any of the body’s joints, including knees, elbows, wrists, and shoulders, leading to discomfort and reduced mobility. Joint pain can range from mild soreness to more intense aching sensations that interfere with daily movements and activities. 
• Influenza (Flu): It is commonly referred to as the flu, is a viral infection that can occur in individuals taking Adtralza. Symptoms include high fever, chills, muscle aches, cough, congestion, runny nose, headaches, and fatigue. The flu can lead to significant discomfort and may require antiviral medications, especially in severe cases or for individuals at higher risk of complications. 
• Fever: Fever, defined as an elevated body temperature above the normal range, is another possible side effect of Adtralza. A fever can be a sign that the body is responding to the medication or fighting off an infection. Symptoms accompanying a fever may include sweating, chills, headache, muscle aches, and general weakness. While mild fevers may resolve on their own, persistent or high-grade fevers require medical attention to determine the underlying cause and appropriate treatment. 
• Allergic Reactions: Although less common, some individuals may experience allergic reactions to Adtralza. Symptoms can range from mild to severe and may include rash, itching, swelling (especially of the face, lips, or throat), dizziness, and difficulty breathing. Severe allergic reactions, known as anaphylaxis, are medical emergencies and require immediate attention.
• Respiratory Symptoms: Coughing, wheezing, or shortness of breath like symptoms may occur in some individuals taking Adtralza. These symptoms can be mild to moderate and may affect breathing comfort and lung function. Respiratory issues can arise from the body’s immune response or as a direct effect of the medication. Managing these symptoms involves monitoring their severity, avoiding respiratory irritants, and seeking medical advice if they worsen or become persistent. 
• Gastrointestinal Issues: This including diarrhea, abdominal pain, and indigestion, may be experienced by some patients on Adtralza. These symptoms can disrupt daily life by causing discomfort, altering appetite, and affecting nutrient absorption. GI issues can result from the body’s response to the medication or other underlying factors. Managing these symptoms involves maintaining a balanced diet, staying hydrated, and using over-the-counter remedies if appropriate. 
• Headache Migraines: In addition to general headaches, some individuals may experience migraine-type headaches while taking Adtralza. Managing migraine headaches involves identifying and avoiding triggers, using prescribed migraine medications, and implementing relaxation techniques. If migraines become frequent or debilitating, consulting a healthcare professional is essential for appropriate treatment strategies.
• Muscle Pain (Myalgia): This pain can affect any muscle group and may range from mild discomfort to more severe aching sensations. Muscle pain can interfere with physical activities, reduce mobility, and impact overall well-being. It may result from the body’s inflammatory response or other mechanisms related to the medication. 

Serious Side Effects of Adtralza

While Adtralza is generally well-tolerated, some individuals may experience serious side effects. These adverse reactions are less common but require immediate medical attention. Below is a comprehensive list of serious side effects associated with Adtralza, each explained in detail to help you understand the potential risks. Always consult your healthcare provider if you experience any of these symptoms.

• Severe Allergic Reactions (Anaphylaxis): A life-threatening allergic reaction that can occur rapidly after taking Adtralza. Symptoms may include difficulty breathing, swelling of the face, lips, tongue, or throat, severe rash or hives, dizziness, and a rapid or weak pulse. This condition requires immediate emergency medical intervention. If you experience signs of anaphylaxis, seek emergency medical help right away. Individuals with a history of severe allergies should inform their healthcare provider before starting Adtralza.
• Serious Infections: Adtralza may increase the risk of serious infections due to its effect on the immune system. These infections can include bacterial, viral, or fungal infections that are more severe than typical colds or flu. Symptoms may include high fever, persistent cough, shortness of breath, severe sore throat, or other signs of infection that do not improve with standard treatment. 
• Tuberculosis (TB): Although rare, Adtralza can increase the risk of developing tuberculosis, especially in individuals who have been exposed to TB or have a history of the disease. Symptoms of TB include a persistent cough lasting more than three weeks, chest pain, coughing up blood, unexplained weight loss, night sweats, and fever. 
• Liver Problems: Adtralza may affect liver function, leading to liver-related side effects. Signs of liver problems include yellowing of the skin or eyes (jaundice), dark urine, severe fatigue, nausea, vomiting, abdominal pain, and unusual bruising or bleeding. Regular monitoring of liver enzymes may be recommended by your healthcare provider during treatment with Adtralza.
• Neurological Events: Although uncommon, serious neurological events such as seizures, severe headaches, or changes in vision can occur while taking Adtralza. These symptoms may indicate an underlying neurological condition that requires immediate medical attention. 
• Blood Disorders: Adtralza may cause abnormalities in blood cell counts, leading to conditions such as neutropenia (low levels of neutrophils), anemia (low red blood cells), or thrombocytopenia (low platelets). Symptoms of blood disorders include unexplained bruising or bleeding, persistent fatigue, weakness, frequent infections, or signs of anemia like shortness of breath and dizziness. 
• Cardiovascular Issues: Although rare, Adtralza may be associated with cardiovascular problems such as hypertension (high blood pressure), palpitations, or chest pain. These symptoms can indicate underlying heart conditions that may require urgent medical evaluation. Persistent or severe cardiovascular symptoms should be addressed promptly to prevent further complications. 
• Gastrointestinal Perforations: In very rare cases, Adtralza may be linked to gastrointestinal perforations, which are serious conditions where a hole forms in the wall of the gastrointestinal tract. Symptoms include severe abdominal pain, fever, chills, nausea, vomiting, and an inability to pass stool or gas. 
• Lupus-like Syndrome: Adtralza has been associated with the development of lupus-like syndrome, an autoimmune condition resembling systemic lupus erythematosus (SLE). Symptoms may include joint pain, skin rashes, fever, fatigue, and kidney problems. This syndrome can affect multiple organ systems and may require discontinuation of Adtralza and initiation of appropriate treatment. If you develop symptoms suggestive of lupus-like syndrome, contact your healthcare provider promptly for evaluation and management.
• Vision Changes: Serious vision changes, including blurred vision, decreased vision, or loss of vision, can occur with Adtralza use. These symptoms may indicate ocular inflammation or other eye-related complications that require immediate medical attention. Persistent or severe vision changes should be evaluated by an eye specialist to prevent potential long-term damage. Regular eye examinations may be recommended during treatment to monitor for any adverse effects on vision.
• Hepatitis B Reactivation: In individuals with a history of Hepatitis B infection, Adtralza may cause reactivation of the virus, leading to severe liver damage. Symptoms include jaundice, dark urine, severe fatigue, abdominal pain, and elevated liver enzymes. It is essential to inform your healthcare provider if you have a history of Hepatitis B before starting Adtralza. Monitoring and antiviral prophylaxis may be necessary to prevent reactivation. If you experience any symptoms of Hepatitis B reactivation, seek medical attention immediately.
• Severe Skin Reactions: Although Adtralza is used to treat eczema, paradoxically, it can sometimes cause severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. These conditions are characterized by widespread skin blistering, peeling, severe rash, and mucosal involvement. They are medical emergencies that require immediate hospitalization and discontinuation of Adtralza. If you develop severe skin reactions, seek urgent medical care to prevent life-threatening complications.
• Immune-Mediated Disorders: Adtralza may trigger immune-mediated disorders, where the immune system attacks the body’s own tissues. This can lead to conditions such as autoimmune hepatitis, vasculitis, or other systemic inflammatory diseases. Symptoms vary depending on the specific disorder but may include unexplained fever, weight loss, persistent pain, or organ-specific symptoms. Early recognition and treatment by a healthcare professional are crucial to manage these potentially serious conditions effectively.
• Progressive Multifocal Leukoencephalopathy (PML): PML is a rare but serious brain infection caused by the John Cunningham (JC) virus, which can occur in individuals with weakened immune systems. Symptoms include difficulty with coordination, changes in personality, impaired speech, and vision problems. PML is often fatal or leads to severe disability. While not commonly associated with Adtralza, the use of immunosuppressive therapies can increase the risk. Immediate medical evaluation is necessary if symptoms suggestive of PML arise.
• Malignancies (Cancer): There is a potential, albeit low, risk of developing certain types of cancer while using Adtralza, as with other biologic therapies that modulate the immune system. Cancers such as lymphoma or skin cancers may occur more frequently in some patients. Early signs include unexplained lumps, persistent pain, changes in skin moles, or unusual bleeding. Regular monitoring and prompt evaluation of suspicious symptoms are essential for early detection and treatment of malignancies. Discuss your personal risk factors with your healthcare provider before starting Adtralza.

[Note: Remember, this list may not cover all possible side effects. Always consult with your healthcare giver for medical advice about side effects.]

Are There Any Warnings for Adtralza? 

While it can be effective in managing symptoms, there are several important warnings and precautions that both patients and healthcare providers should be aware of to ensure safe and effective use. Below is a comprehensive list of serious warnings associated with Adtralza, each explained in detail to help you understand the potential risks involved.

• Severe Allergic Reactions: Anaphylaxis is a rare but life-threatening allergic reaction that can occur after taking Adtralza. Symptoms include difficulty breathing, swelling of the face, lips, tongue, or throat, severe rash or hives, dizziness, and a rapid or weak pulse. If any of these symptoms arise, it is crucial to seek emergency medical attention immediately. 
• Serious Infections: Adtralza may increase the risk of serious infections due to its impact on the immune system. These infections can include bacterial, viral, or fungal infections that are more severe than typical colds or flu. Symptoms may involve high fever, persistent cough, difficulty breathing, severe sore throat, or other signs that do not improve with standard treatments.
• Malignancies (Cancer): There is a potential risk of developing certain types of cancer, such as lymphoma or skin cancers, while using Adtralza. Although the risk is considered low, it is important for patients to be vigilant for any unusual lumps, persistent pain, changes in skin moles, or other signs that might indicate cancer. Early detection and treatment of malignancies can significantly improve outcomes.
• Hypersensitivity Reactions: In addition to anaphylaxis, Adtralza can cause other hypersensitivity reactions, including rash, itching, or swelling that are not life-threatening but still require medical attention. These reactions may occur shortly after an injection or develop over time. If symptoms of a hypersensitivity reaction occur, patients should contact their healthcare provider to determine whether to continue or adjust the treatment.
• Immunogenicity (Development of Antibodies): Adtralza may lead to the development of antibodies against the medication, potentially reducing its effectiveness or causing adverse reactions. Patients might experience a decrease in the drug’s efficacy, leading to a worsening of eczema symptoms. Monitoring for signs of decreased effectiveness, such as increased redness, itching, or inflammation, is important. 
• Liver Function Impairment: Although rare, Adtralza may affect liver function, leading to liver-related side effects such as jaundice (yellowing of the skin or eyes), dark urine, severe fatigue, nausea, vomiting, abdominal pain, and unusual bruising or bleeding. Regular monitoring of liver enzymes may be recommended during treatment. Patients should report any symptoms indicative of liver dysfunction immediately to their healthcare provider for appropriate evaluation and management.
• Use During Pregnancy and Breastfeeding: The safety of Adtralza during pregnancy and breastfeeding has not been fully established. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the potential risks and benefits of using Adtralza with their healthcare provider. 
• Cardiovascular Issues: Although rare, Adtralza may be associated with cardiovascular problems such as hypertension (high blood pressure), palpitations, or chest pain. These symptoms can indicate underlying heart conditions that may require urgent medical evaluation. Persistent or severe cardiovascular symptoms should be addressed promptly to prevent further complications. Patients with pre-existing cardiovascular conditions should be closely monitored while using Adtralza.
• Neurological Events: Serious neurological events, including seizures, severe headaches, or significant changes in vision, can occur in some patients taking Adtralza. These symptoms may indicate underlying neurological conditions that require immediate medical attention. If a patient experiences sudden or severe neurological symptoms, such as loss of consciousness, difficulty speaking, numbness or weakness in limbs, or significant changes in vision, they should seek emergency medical care to prevent potential complications.
• Gastrointestinal Perforations: In very rare instances, Adtralza may be linked to gastrointestinal perforations, which are serious conditions where a hole forms in the wall of the gastrointestinal tract. Symptoms include severe abdominal pain, fever, chills, nausea, vomiting, and an inability to pass stool or gas. If any of these symptoms arise, patients should seek emergency medical care without delay.
• Lupus-like Syndrome: Adtralza has been associated with the development of lupus-like syndrome, an autoimmune condition resembling systemic lupus erythematosus (SLE). Symptoms may include joint pain, skin rashes, fever, fatigue, and kidney problems. This syndrome can affect multiple organ systems and may require discontinuation of Adtralza and initiation of appropriate treatment. 
• Vision Changes: Serious vision changes, including blurred vision, decreased vision, or loss of vision, can occur with Adtralza use. These symptoms may indicate ocular inflammation or other eye-related complications that require immediate medical attention. Persistent or severe vision changes should be evaluated by an eye specialist to prevent potential long-term damage. 
• Hepatitis B Reactivation: In individuals with a history of Hepatitis B infection, Adtralza may cause reactivation of the virus, leading to severe liver damage. Symptoms include jaundice, dark urine, severe fatigue, abdominal pain, and elevated liver enzymes. It is essential to inform your healthcare provider if you have a history of Hepatitis B before starting Adtralza. 
• Severe Skin Reactions: Although Adtralza is used to treat eczema, paradoxically, it can sometimes cause severe skin reactions such as Stevens-Johnson syndrome or toxic epidermal necrolysis. These conditions are characterized by widespread skin blistering, peeling, severe rash, and mucosal involvement. 
• Immune-Mediated Disorders: Adtralza may trigger immune-mediated disorders, where the immune system attacks the body’s own tissues. This can lead to conditions such as autoimmune hepatitis, vasculitis, or other systemic inflammatory diseases. Symptoms vary depending on the specific disorder but may include unexplained fever, weight loss, persistent pain, or organ-specific symptoms. 

What Are the Adtralza Precautions?

Adtralza is highly effective, but certain precautions must be taken to ensure its safe and optimal use. These precautions are distinct from warnings and focus on preventive measures and considerations to minimize risks while using Adtralza. Below is a comprehensive list of precautions associated with this medication.

• Medical History Evaluation: Before initiating Adtralza therapy, it is crucial to provide your healthcare provider with a complete medical history. This includes any history of immune system disorders, recurrent infections, or other chronic health conditions. Understanding your medical background helps the healthcare provider assess whether Adtralza is appropriate for you and determine if additional monitoring is necessary. 
• Infection Risk Assessment: Adtralza can potentially increase the risk of infections by modulating the immune system. Therefore, assessing your susceptibility to infections before starting treatment is essential. If you have a history of frequent or severe infections, your healthcare provider may decide to postpone Adtralza therapy or implement additional preventive measures. 
• Vaccination Status Review: Prior to starting Adtralza, it is important to review your vaccination history with your healthcare provider. Live vaccines should generally be avoided during Adtralza therapy because the medication may impair the immune system’s ability to respond adequately to the vaccine. If vaccinations are necessary, they should ideally be administered before initiating Adtralza treatment.
• Pregnancy and Breastfeeding Considerations: The safety of Adtralza during pregnancy and breastfeeding has not been fully established. If you are pregnant, planning to become pregnant, or breastfeeding, it is essential to discuss the potential risks and benefits of using Adtralza with your healthcare provider. In some cases, the healthcare provider may recommend discontinuing Adtralza to protect the health of both the mother and the baby. 
• Liver and Kidney Function Monitoring: Although specific dose adjustments for liver or kidney impairment have not been well-characterized for Adtralza, individuals with significant liver or kidney disease should be closely monitored during treatment. Impaired liver or kidney function can affect how Adtralza is metabolized and eliminated from the body, potentially altering its efficacy and increasing the risk of side effects. 
• Concurrent Use of Immunosuppressive Therapies: If you are taking other immunosuppressive medications alongside Adtralza, there may be an increased risk of infections or immune-related side effects. It is vital to inform your healthcare provider about all medications, including over-the-counter drugs and supplements, that you are currently taking. 
• Allergy History Disclosure: Inform your healthcare provider about any known allergies, particularly to tralokinumab or any other components of Adtralza. Allergic reactions can range from mild skin rashes to severe anaphylaxis. Knowing your allergy history helps the healthcare provider take necessary precautions, such as premedicating or selecting alternative therapies, to prevent allergic reactions. 
• Age-Related Considerations: Adtralza is approved for use in adults with moderate-to-severe atopic dermatitis. Its safety and efficacy in pediatric populations have not been established, and therefore, it should not be used in individuals outside the approved age range unless specifically directed by a healthcare provider. 
• Regular Treatment Response Monitoring: Ongoing evaluation of your response to Adtralza is essential to determine its effectiveness and to identify any emerging side effects. Regular follow-up appointments allow your healthcare provider to assess improvements in your atopic dermatitis symptoms and make necessary adjustments to your treatment regimen. 
• Proper Injection Technique and Site Rotation: Adtralza is administered via subcutaneous injection, and proper injection technique is vital to minimize injection site reactions and ensure effective drug delivery. Rotating injection sites (e.g., alternating between thighs, abdomen, or upper arms) helps prevent skin irritation, lumps, or scar tissue formation at the injection site.
• Avoidance of Live Vaccines During Therapy: While undergoing Adtralza therapy, it is advisable to avoid live vaccines due to the potential for an impaired immune response. Live vaccines contain weakened forms of the virus or bacteria, which can pose a risk to individuals with compromised immune systems. 
• Moderation of Alcohol Consumption: Although there are no direct interactions between Adtralza and alcohol, excessive alcohol consumption can negatively impact your immune system and overall health. High alcohol intake may exacerbate side effects such as fatigue or nausea and potentially interfere with your body’s ability to respond to Adtralza treatment effectively. 
• Caution When Driving or Operating Machinery: While Adtralza is not known to cause drowsiness, some side effects such as headaches or dizziness may impair your ability to perform tasks that require full attention, such as driving or operating machinery. If you experience these side effects, it is important to take appropriate precautions, such as avoiding these activities until the symptoms subside. 
• Maintaining Hydration and a Balanced Diet: Staying well-hydrated and maintaining a balanced diet can support your overall health and help manage some of the side effects of Adtralza, such as nausea or fatigue. Proper nutrition and hydration enhance your body’s ability to respond to treatment and recover from any adverse effects. 
• Informing All Healthcare Providers: It is essential to inform all of your healthcare providers, including dentists and specialists, that you are taking Adtralza. This information is crucial for coordinating care, especially in situations that may require additional medical interventions or treatments. 
• Gradual Discontinuation of Treatment: Do not abruptly stop taking Adtralza without consulting your healthcare provider, even if you experience side effects or notice improvements in your atopic dermatitis. Gradual discontinuation may be necessary to prevent a sudden flare-up of symptoms or other complications. 
• Regular Health Check-Ups and Blood Tests: Regular health check-ups, including blood tests, may be recommended to monitor your body’s response to Adtralza treatment. These assessments help detect any potential side effects early, such as changes in liver or kidney function, and ensure that Adtralza is working effectively. 
• Awareness of Potential Reduced Effectiveness: Some patients may experience a reduction in Adtralza’s effectiveness over time, leading to a resurgence of atopic dermatitis symptoms. Being aware of this possibility allows you to communicate promptly with your healthcare provider if you notice any worsening of your condition. 
• Attention to Mental Health: Managing a chronic condition like atopic dermatitis can have psychological impacts, including stress, anxiety, or depression. While not directly related to Adtralza, being mindful of your mental health is important during treatment. 

What Are the Contraindications of Adtralza?

• Hypersensitivity to Tralokinumab or Any Component of the Formulation: If you have a history of severe allergic reactions to similar medications or to tralokinumab itself, you should avoid using Adtralza. Symptoms of an allergic reaction may include rash, itching, swelling, severe dizziness, or difficulty breathing. It is essential to inform your healthcare provider about any allergies you have before starting treatment to prevent adverse reactions.
• Active Serious Infections: Adtralza can suppress the immune system, increasing the risk of developing or worsening serious infections. Therefore, it is contraindicated in individuals with active serious infections, including tuberculosis (TB), bacterial, fungal, or viral infections. Signs of serious infection include fever, chills, persistent cough, difficulty breathing, or other severe symptoms. 
• History of Recurrent or Chronic Infections: Individuals with a history of recurrent or chronic infections may be at higher risk of developing serious infections while using Adtralza. Conditions that predispose to recurrent infections, such as chronic obstructive pulmonary disease (COPD) or immunodeficiency disorders, may make Adtralza unsuitable for use.
• Severe Immunodeficiency Conditions: Adtralza is contraindicated in patients with severe immunodeficiency conditions, including those undergoing treatment for malignancies that compromise the immune system, or individuals with primary immunodeficiency diseases. The immunomodulatory effects of Adtralza can exacerbate these conditions, leading to increased susceptibility to infections and other immune-related complications. 
• Unstable Medical Conditions: This includes uncontrolled cardiovascular disease, significant liver or kidney dysfunction, or other serious health issues that require immediate medical attention. Stabilizing these conditions before starting Adtralza can help ensure that the medication is both safe and effective for managing atopic dermatitis without introducing additional health risks.
• Pregnancy and Breastfeeding: The safety of Adtralza during pregnancy and breastfeeding has not been fully established. While not always an absolute contraindication, it is crucial to discuss potential risks and benefits with your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. In some cases, the healthcare provider may recommend discontinuing Adtralza to protect the health of both the mother and the baby or may consider alternative treatments to manage atopic dermatitis effectively while minimizing potential risks.

What If You Miss a Dose of Adtralza?

If you miss a dose of Adtralza, it’s important to take action promptly to maintain the effectiveness of your treatment. As soon as you remember the missed dose, administer it, provided there is still enough time before your next scheduled injection. However, if it is nearly time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the missed one, as this could increase the risk of side effects. Missing a single dose is unlikely to significantly impact your treatment, but it’s essential to stay consistent with your injection schedule to achieve the best possible results in managing your atopic dermatitis. 

[Note: If you have missed a dose of your medication and are unsure about when to take the next one, immediately consult your doctor or pharmacist.]

What Happens If You Take Too Much of Adtralza?

If you take too much of Adtralza, it may increase the risk of experiencing adverse side effects or severe reactions. Overdosing on Adtralza can lead to intensified injection site reactions, such as excessive redness, swelling, or pain. Additionally, you might be more susceptible to serious infections due to the heightened immunosuppressive effects of the medication. Other potential symptoms of an overdose could include severe allergic reactions, such as difficulty breathing, swelling of the face or throat, and widespread rash. To prevent the risk of overdose, always adhere strictly to the prescribed dosing schedule and follow your healthcare provider’s instructions carefully when using Adtralza.

[Note: If you consumed more than the recommended dose, get medical help right away, or call the Poison Help line at 1-800-222-1222.]

How to Store Adtralza?

Proper storage of Adtralza is essential to ensure that the medication remains effective and safe for use throughout your treatment. Adhering to the recommended storage guidelines helps maintain the drug’s stability, prevents degradation, and minimizes the risk of contamination or reduced efficacy. Below are the detailed steps and considerations for storing Adtralza correctly.

• Store Adtralza in a refrigerator at 2°C to 8°C (36°F to 46°F).
• Keep the medication in its original packaging to protect it from direct light, which can degrade the drug.

• If necessary, Adtralza can be kept at room temperature (up to 25°C or 77°F) for a maximum of 7 days.
• Do not exceed the 7-day period at room temperature. After this time, discard any unused medication to ensure safety and efficacy.

• Freezing Adtralza can damage the medication, rendering it ineffective. Ensure it remains refrigerated or within the specified room temperature range.

• Allow the medication to reach room temperature for 30 minutes before injection to reduce discomfort at the injection site.
• Before each use, inspect Adtralza for any changes in appearance, such as cloudiness or particles. Do not use it if the solution appears altered.

• If you need to transport Adtralza, use a cool pack to keep it within the recommended temperature range. Avoid exposing it to extreme temperatures during travel.
• Ensure the medication is stored securely to prevent damage or exposure to inappropriate temperatures.

• Properly dispose of any expired or unused Adtralza. Follow local regulations for medication disposal or consult your pharmacist for guidance.
• Store Adtralza away from children and pets to prevent accidental ingestion or misuse.
• Ensure the storage area is dry to prevent moisture from affecting the medication.

[Note: Discuss with your healthcare professional about the proper disposal of any unused medicine and any questions you may have regarding its storage.]

What Medications Interact with Adtralza?

Adtralza has not demonstrated significant interactions with other medications. Studies indicate that tralokinumab does not significantly affect the pharmacokinetics of drugs metabolized by cytochrome P450 enzymes, such as caffeine, warfarin, metoprolol, omeprazole, and midazolam. Therefore, clinically relevant interactions between tralokinumab and these drugs are not expected. 

However, it is recommended to avoid the concurrent use of live vaccines with Adtralza, as the combination has not been studied. Patients receiving Adtralza may receive inactivated or non-live vaccines without adverse interactions. As with any medication, it is important to inform your healthcare provider about all prescription, over-the-counter, and herbal products you are using to ensure safety and efficacy. 

[Note: This isn’t a complete list, and there could be other drugs that interact with Adtralza. Make sure to tell your doctor about any prescription, over-the-counter medicines, and herbal products you’re taking.]

What Are the Adtralza Alternatives?

Managing skin conditions often requires exploring different treatment options to find what works best for each individual. If Adtralza isn’t the right fit, several alternatives are available, ranging from biologics to immunosuppressants and topical treatments, offering diverse approaches to symptom relief.

• Dupixent (dupilumab)
• Neoral, Sandimmune (cyclosporine)
• Rheumatrex, Trexall (methotrexate)
• Imuran (azathioprine)
• CellCept (mycophenolate mofetil)
• Stelara (ustekinumab)
• Cosentyx (secukinumab)
• Taltz (ixekizumab)
• Otezla (apremilast)
• Xeljanz (tofacitinib)
• Olumiant (baricitinib)
• Rinvoq (upadacitinib)
• Protopic (tacrolimus)
• Elidel (pimecrolimus)
• Various Brand Names (topical corticosteroids)

[Note: Your doctor will choose what’s best for you. Don’t use any of these alternative medications without consulting your healthcare provider. Taking them by yourself may cause serious side effects.]

Adtralza Cost & Coupons

Managing your atopic dermatitis shouldn’t strain your budget. While Adtralza is a reliable biologic treatment for controlling and preventing moderate-to-severe eczema symptoms, its cost can vary between regions, making consistent use expensive. At Polar Bear Meds, we focus on offering affordable, high-quality medication so you can achieve clearer skin without financial stress. If you’re searching for a budget-friendly solution, buy Adtralza online from Canada and benefit from top-quality medicine at a lower price. To maximize your savings, buy Adtralza with coupon by entering the code “WELCOMEPB10” at checkout for 10% off your first order. With our competitive rates, trusted suppliers, and fast delivery, you’ll receive genuine Adtralza without breaking the bank. Don’t let eczema disrupt your comfort—purchase Adtralza today and enjoy convenient, cost-effective relief delivered directly to your door!

Frequently Asked Questions

How long does it take for Adtralza to show results?

The response to Adtralza varies from person to person, but many patients begin to see noticeable improvements in their eczema symptoms within 2 to 4 weeks of starting treatment. The full effects may take up to 16 weeks, so it’s important to continue using Adtralza as prescribed and follow up with your healthcare provider for progress assessment.

Can Adtralza be used alongside topical treatments for eczema?

Yes, Adtralza can be used alongside topical corticosteroids, moisturizers, and other eczema treatments to enhance symptom management. Many patients use Adtralza as part of a combination therapy plan, especially during flare-ups. However, your healthcare provider may adjust the use of other treatments depending on how well Adtralza controls your symptoms over time.

Does Adtralza affect the immune system?

Adtralza modulates the immune system by specifically targeting IL-13, a protein involved in eczema-related inflammation. Unlike general immunosuppressants, Adtralza does not broadly suppress the entire immune system, meaning it has a lower risk of serious infections compared to traditional immunosuppressive drugs. However, patients should still be cautious, especially if they have a history of chronic infections, and report any signs of illness to their doctor.

Can I stop Adtralza once my eczema improves?

Adtralza is a long-term treatment designed to control moderate-to-severe eczema by reducing inflammation over time. Stopping the medication abruptly may lead to a return of symptoms or flare-ups. If you are considering discontinuing Adtralza, consult your healthcare provider to discuss a proper treatment plan and alternative options to maintain symptom control.

Does Adtralza have any impact on eye health?

Yes, some patients using Adtralza have reported eye-related side effects, such as conjunctivitis (pink eye), dry eyes, and keratitis (inflammation of the cornea). While these effects are usually mild to moderate, it is important to monitor any changes in vision, eye discomfort, or persistent irritation and consult an eye specialist or your healthcare provider if symptoms develop.

Can Adtralza be used for conditions other than atopic dermatitis?

Currently, Adtralza is only approved for the treatment of moderate-to-severe atopic dermatitis. It specifically targets IL-13, a key protein involved in eczema-related inflammation. While research is ongoing to explore its potential use for other inflammatory conditions, it is not currently approved for any other medical conditions. Always consult your healthcare provider before using Adtralza for off-label purposes.

Our Guarantee

At PolarBearMeds.com, we assure you the most affordable price to buy Adtralza online from Canada. Rest easy knowing that your order will be dispatched from a reputable Licensed Canada Pharmacy Online, adhering to the highest standards of quality and authenticity. Our discounted medications are shipped directly from Canada to your doorstep, ensuring a swift and secure delivery experience. To conveniently buy Adtralza online at a substantial cost, call us at 1-888-779-2193 toll-free.